Loading...
Price History
Market Data
| Market Cap | 39.81M |
| P/E Ratio | - |
| P/B Ratio | 1.22 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 1.68 |
| Current Ratio | 0.89 |
| Currency | USD |
Key Financial Metrics
182.67M
Revenue
-64.87M
Net Income
-
EPS (Diluted)
-54.84M
Free Cash Flow
Profitability
Gross Margin
30.2%
Operating Margin
-32.3%
Net Profit Margin
-35.5%
EBITDA
-49.97M
Returns & Efficiency
Return on Assets (ROA)
-73.7%
Return on Equity (ROE)
-198.0%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
87.97M
Total Debt
-
Debt to Equity
1.68x
Current Ratio
0.89
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| HQ | DELRAY BEACH, FL |
| Fiscal Year | 2025 |
Peers
105.38B
P/E: --
CVS HEALTH CORP
CVS
105.38B
P/E: --
BIOSCRIP, INC.
OPCH
5.89B
P/E: --
1.93B
P/E: 44.9
1.93B
P/E: 44.9
4.19M
P/E: --
3.04M
P/E: --
3.04M
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$39.81M
P/E Ratio (TTM)-
Price to Book1.22
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin30.2%
Operating Margin-32.3%
Net Margin-35.5%
ROE-198.0%
ROA-73.7%
Leverage & Liquidity
Debt to Equity1.68
Current Ratio0.89
Total Debt-
Total Assets$87.97M
Stockholders' Equity$32.77M
Income Statement (FY 2025)
Revenue$182.67M
Gross Profit$55.22M
Operating Income$-59.00M
Net Income$-64.87M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$-54.84M
Cash & Equivalents$26.91M
Revenue Growth-19.5%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 420 SOUTH CONGRESS AVENUE DELRAY BEACH, FL 33445 |
| Phone | (561) 426-4444 |
| Incorporated | FL, US |
| EIN | 650680967 |
| Fiscal Year End | 0331 |
| Shares Outstanding | 21.01M |
| Stockholders' Equity | $32.77M |
| Cash & Equivalents | $26.91M |
Recent Filings
View All
SCHEDULE 13D
Beneficial Ownership Report
Schedule 13D - beneficial ownership over 5%
Filed: 2026-02-11
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-02-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-12-19
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-12-19
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-12-10
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-10-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-02-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-07
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-06-24
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-06-14
Local
10-K/A
Amended Annual Report
Amendment to previously filed annual report
Filed: 2024-04-15
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-04-15
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-10-31
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-08-02
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | PETMED EXPRESS INC |
| Ticker | PETS |
| Exchange | -- |
| Sector | Retail Trade |
| Industry | -- |
| Headquarters | DELRAY BEACH, FL |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 39.81M |
| Revenue | 182.67M |
| Net Income | -64.87M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -35.5% |
| ROE | -198.0% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...